Report overview
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
This report contains market size and forecasts of Drug Eluting Balloon for Coronary Artery Disease in global, including the following market information:
Global Drug Eluting Balloon for Coronary Artery Disease Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global Drug Eluting Balloon for Coronary Artery Disease Market Sales, 2018-2023, 2023-2032, (Units)
Global top five Drug Eluting Balloon for Coronary Artery Disease companies in 2022 (%)
The global Drug Eluting Balloon for Coronary Artery Disease market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
Paclitaxel Coated Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Drug Eluting Balloon for Coronary Artery Disease include B. Braun, Yinyi, Eurocor and Biotronic, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drug Eluting Balloon for Coronary Artery Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Eluting Balloon for Coronary Artery Disease Market, by Type, 2018-2023, 2023-2032 ($ Millions) & (Units)
Global Drug Eluting Balloon for Coronary Artery Disease Market Segment Percentages, by Type, 2022 (%)
Paclitaxel Coated
Other Coated
Global Drug Eluting Balloon for Coronary Artery Disease Market, by Application, 2018-2023, 2023-2032 ($ Millions) & (Units)
Global Drug Eluting Balloon for Coronary Artery Disease Market Segment Percentages, by Application, 2022 (%)
Hospitals
ASCs
Catheterization Laboratory
Global Drug Eluting Balloon for Coronary Artery Disease Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions) & (Units)
Global Drug Eluting Balloon for Coronary Artery Disease Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Balloon for Coronary Artery Disease revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drug Eluting Balloon for Coronary Artery Disease revenues share in global market, 2022 (%)
Key companies Drug Eluting Balloon for Coronary Artery Disease sales in global market, 2018-2023 (Estimated), (Units)
Key companies Drug Eluting Balloon for Coronary Artery Disease sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
B. Braun
Yinyi
Eurocor
Biotronic
